Suppr超能文献

某些新合成的麦角灵衍生物对兔离体主动脉5-HT2受体和α-肾上腺素能受体的构效关系研究

Structure-activity study of some newly synthesized ergoline derivatives on 5-HT2 receptors and alpha-adrenoceptors in rabbit isolated aorta.

作者信息

Krisch I, Budihna M V, Rucman R

机构信息

Research and Development Department, LEK Pharmaceuticals, Ljubljana, Slovenia/Yugoslavia.

出版信息

Pharmacology. 1992;45(4):195-208. doi: 10.1159/000138998.

Abstract

In a structure-activity study, carried out in rabbit isolated aorta, the effect of different structural modifications in the ergoline nucleus upon the activity at 5-HT2 receptors and alpha-adrenoceptors was determined. 9,10-didehydro-N-methyl-N-(2-propynyl)-6-methylergoline-8 beta-carboxamide (LEK 8842) was chosen as the basic backbone of this study. The parent compound LEK 8842 showed strong alpha-adrenoceptor agonistic activity and partial 5-HT2 receptor agonistic activity, and its potency (pD2 = 6.41) was comparable with that of 5-hydroxytryptamine (5-HT, pD2 = 6.84) and noradrenaline (pD2 = 6.82). Hydrogenation of the double bond in the position 9,10 (LEK 8822) attenuated the potency (pD2 = 5.35) as well as the intrinsic activity on alpha-adrenoceptors and eliminated 5-HT2 receptor agonistic activity. LEK 8822 acted on the alpha-adrenoceptors not only as a partial agonist but also as a competitive antagonist of responses elicited by noradrenaline. When tested against 5-HT, LEK 8822 acted as an antagonist. Bromination in position 2 yielded the derivative LEK 8841 with no agonistic activity at concentrations up to 3 mumol/l, yet the affinity for 5-HT2 receptors and alpha-adrenoceptors was preserved. LEK 8841 was the only one that acted as pure simple competitive antagonist of responses elicited by 5-HT (pA2 = 7.93) and noradrenaline (pA2 = 6.45). Its activity was qualitatively similar to that observed with the 5-HT2/alpha-adrenoceptor antagonist ketanserin which was tested for comparison. Concerning selectivity for 5-HT2 receptors versus alpha-adrenoceptors, LEK 8841 proved to be more selective for 5-HT2 receptors than ketanserin. pA2 values for ketanserin antagonistic activity to 5-HT and to noradrenaline were 8.22 and 7.48, respectively. Finally, quaternization in the N(6) position (LEK 8827) almost completely eliminated affinity for 5-HT2 receptors and for alpha-adrenoceptors. This study has shown that relatively small modifications in the structure of the ergoline system led to pronounced changes in the affinity as well as intrinsic activity at both receptors studied.

摘要

在一项对兔离体主动脉进行的构效关系研究中,测定了麦角灵核中不同结构修饰对5-HT2受体和α-肾上腺素受体活性的影响。选择9,10-二脱氢-N-甲基-N-(2-丙炔基)-6-甲基麦角灵-8β-甲酰胺(LEK 8842)作为本研究的基本骨架。母体化合物LEK 8842表现出较强的α-肾上腺素受体激动活性和部分5-HT2受体激动活性,其效价(pD2 = 6.41)与5-羟色胺(5-HT,pD2 = 6.84)和去甲肾上腺素(pD2 = 6.82)相当。9,10位双键氢化(LEK 8822)降低了效价(pD2 = 5.35)以及对α-肾上腺素受体的内在活性,并消除了5-HT2受体激动活性。LEK 8822作用于α-肾上腺素受体时不仅作为部分激动剂,还作为去甲肾上腺素引发反应的竞争性拮抗剂。与5-HT进行测试时,LEK 8822作为拮抗剂。2位溴化得到衍生物LEK 8841,在浓度高达3 μmol/L时无激动活性,但对5-HT2受体和α-肾上腺素受体的亲和力得以保留。LEK 8841是唯一对5-HT(pA2 = 7.93)和去甲肾上腺素(pA2 = 6.45)引发的反应起纯简单竞争性拮抗剂作用的化合物。其活性在性质上与用于比较测试的5-HT2/α-肾上腺素受体拮抗剂酮色林观察到的活性相似。关于对5-HT2受体与α-肾上腺素受体的选择性,LEK 8841对5-HT2受体的选择性比酮色林更高。酮色林对5-HT和去甲肾上腺素拮抗活性的pA2值分别为8.22和7.48。最后,N(6)位季铵化(LEK 8827)几乎完全消除了对5-HT2受体和α-肾上腺素受体的亲和力。本研究表明,麦角灵系统结构中相对较小的修饰导致了所研究的两种受体的亲和力以及内在活性发生显著变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验